Patent · US Active

Transplantation therapies

US10723744B2 · kind B2 · utility

0Cited by

14References

17Claims

0Family size

Inventors

Jonathan Alexander · Roswell, US
April C. Carpenter · Cincinnati, US
Trevor Percival Castor · Arlington, US

Key dates

Filing date	Jun 8, 2018
Grant date	Jul 28, 2020
Priority date	—
Expiry date	Jun 8, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Embodiments of the present invention are directed to methods and dosage forms for treating inflammation and rejection in transplantation injuries with Bryostatin-1, Bryostatin-1 analogs and pharmaceutically acceptable salts thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.